CSBR (Champions Oncology Corp) Pangali Forward P/E

Simbol resmi perusahaan Champions Oncology, Inc. (CSBR)

The outsourcing of cloud genetic analysis and partner networks influences the dynamics, which confirms the price-to-earnings forecast for Champions Oncology (CSBR). The value of 0.00 determines the current status of the parameter. Unique tumor databases and ties with pharma behemoths ensure business resilience, while the implementation of robots in media dosing accelerates research validation, strengthening the market position of Champions Oncology.

championsoncology.com - Pangali Forward P/E CSBR (periode 04.07.2022 - 17.11.2026)

Ringkesan rincian data analitis Champions Oncology (CSBR)

Analisis fundamental perusahaan:Champions Oncology
Produk merek Champions Oncology Corp

Forward P/E determines the stock price relative to expected earnings, allowing an investor to assess the degree of overpayment for an asset based on projected cash flows. By analyzing the fluctuations in the forward P/E of Champions Oncology (CSBR), one can observe how the risks of reduced biotech sector spending on preclinical research and the high cost of maintaining bio-models at Champions Oncology (CSBR) pressure margins, adjusting market expectations for the business valuation.

Pesaing langsung

Pangali Forward P/E ONC|HALO (Halozyme Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (revmed.com)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Bio (BCAX) - Rega marang bathi mangsa ngarep|Personalis Corp - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Inc) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Systems, Inc. DCTH|Prakiraan rega marang bathi YMAB (Y-mAbs Corp)|Pangali Forward P/E Aura Bio (AURA)|Pangali Forward P/E CADL (Candel Therapeutics Inc.)|ARAY - Prakiraan rega marang bathi|SLS - Rega marang bathi mangsa ngarep|Actuate Therapeutics - Rasio kapitalisasi marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|TuHURA (HURA) - Pangali Forward P/E|TARA (Protara Therapeutics Inc) - Pangali Forward P/E|FATE: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E WHWK|TCRX (TScan) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E XBIT (XBiotech Inc.)|Pangali mangsa ngarep rega marang bathi CVM|OS Therapies Inc. - Pangali Forward P/E|RADX - Pangali Forward P/E|ARTV: Pangali Forward P/E|ANL: Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi VERU|TPST: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep xiliotx.com (XLO)|Renovaro - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Mural Oncology MURA|KAPA - Prakiraan rega marang bathi|OKUR - Rega marang bathi mangsa ngarep|GDTC - Pangali Forward P/E|Curis, Inc. (CRIS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Apollomics, Inc.|Prakiraan rega marang bathi THAR|Rasio rega marang bathi mangsa ngarep ADVB (Advanced Biomed)|Prakiraan rega marang bathi GNPX (Genprex, Inc)|CLDI: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep sunshinebiopharma.com SBFM|XBIO - Prakiraan rega marang bathi|SLRX: Prakiraan rega marang bathi|Purple Biotech - Rasio kapitalisasi marang bathi mangsa ngarep|American Oncology Network (AONC) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi mangsa ngarep BGNE|Prakiraan rega marang bathi CKPT|Rega marang bathi mangsa ngarep ELEV|Pangali Forward P/E ICAD|Pangali Forward P/E Ikena Oncology Inc. (IKNA)|Pangali Forward P/E NTBL (Notable Labs Ltd)|Kapitalisasi marang proyeksi bathi Viracta Therapeutics (VIRX)|MOR: Prakiraan rega marang bathi|NAYA (NAYA Bio) - Rasio rega marang bathi mangsa ngarep|AAPGV: Pangali Forward P/E